SHFH — Scientist Home Future Health Share Price
- $45.06m
- $44.99m
- $0.20m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 397.39 | ||
| Price to Tang. Book | 397.39 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 220.82 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -53.89% | ||
| Return on Equity | -431.65% | ||
| Operating Margin | -113.55% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $m | n/a | n/a | n/a | 0.12 | 0.2 | n/a | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Scientist Home Future Health Ltd is a company principally engaged in the retail trading of health supplements and topical creams. The Company offers six primary products, comprising health supplements and topical creams developed to address specific health concerns, such as Scientist Home Vein Cream, Scientist Home Calcification Cream, Scientist Home Spermaceti Cream, Scientist Home Bone Gelatine Hydrolysate, Scientist Home Mixed Gelatine Hydrolysate, and Scientist Home High Concentration Proteinase.
Directors
- Last Annual
- December 31st, 2025
- Last Interim
- December 31st, 2025
- Incorporated
- July 3rd, 2024
- Public Since
- January 1st, 1970
- No. of Shareholders
- 30
- No. of Employees
- 7
- Sector
- Specialty Retailers
- Industry
- Consumer Cyclicals
- Exchange
Pink Sheets on Nasdaq
- Shares in Issue
- 23,716,000

- Address
- 0, 0, 00000
- Web
- https://scientisthomefuturehealth.com/
- Phone
- Auditors
- JP CENTURION & PARTNERS PLT
Similar to SHFH
Taishengtang
Pink Sheets on Nasdaq
Arion
Pink Sheets on Nasdaq
Avolta AG
Pink Sheets on Nasdaq
bebe stores
Pink Sheets on Nasdaq
Beter Bed Holding BV
Pink Sheets on Nasdaq
FAQ
As of Today at 23:07 UTC, shares in Scientist Home Future Health are trading at $1.90. This share price information is delayed by 15 minutes.
Shares in Scientist Home Future Health last closed at $1.90 and the price had moved by over the past 365 days. In terms of relative price strength the Scientist Home Future Health share price has matched the S&P500 Index by over the past year.
There is no consensus recommendation for this security.
Find out moreScientist Home Future Health does not currently pay a dividend.
Scientist Home Future Health does not currently pay a dividend.
Scientist Home Future Health does not currently pay a dividend.
To buy shares in Scientist Home Future Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of $1.90, shares in Scientist Home Future Health had a market capitalisation of $45.06m.
Here are the trading details for Scientist Home Future Health:
- Country of listing: United States
- Exchange: PNK
- Ticker Symbol: SHFH
Based on an overall assessment of its quality, value and momentum Scientist Home Future Health is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Scientist Home Future Health. Over the past six months, its share price has matched the S&P500 Index by .
As of the last closing price of $1.90, shares in Scientist Home Future Health were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Scientist Home Future Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at $1.90.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Scientist Home Future Health's directors





